Takara Bio Inc (4974)

1,767.0 -33.0 (-1.83%)
Close JPY Disclaimer

4974 Financial Summary

For the fiscal year ended 31 March 2022, TAKARA BIO INC. revenues increased 47% to Y67.7B. Net income applicable to common stockholders increased from Y9.55B to Y19.85B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Subsidy increase from Y517M to Y4.47B (income), Other increase of 49% to Y94M (income).
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
4974
Gross margin TTM 69.44%
Operating margin TTM 37.48%
Net Profit margin TTM 26.65%
Return on Investment TTM 20.06%
Total Revenue
Net Income
Title
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Total Revenue 14,102 22,040 14,108 16,279
Gross Profit 10,125 15,111 10,605 10,356
Operating Income 4,539 8,217 5,822 5,601
Net Income 3,907 5,486 4,354 3,984
Clear All
0Selected
Please try another search
4974
Quick Ratio MRQ 3.37
Current Ratio MRQ 5.93
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
Total Assets
Total Liabilities
Title
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Total Assets 111,488 115,712 106,116 104,777
Total Liabilities 13,064 19,839 16,846 20,184
Total Equity 98,424 95,873 89,270 84,593
Clear All
0Selected
Please try another search
4974
Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow 34.88%
Cash
Net Change in Cash
Title
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Cash From Operating Activities 3,766 6,985 15,400 9,915
Cash From Investing Activities -294 -7,071 -13,380 -10,686
Cash From Financing Activities -3,854 -2,070 -2,034 -1,992
Net Change in Cash 309 -1,148 626 -2,195
Clear All
0Selected
Please try another search

* In Millions of JPY (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles